November 4, 2022
Opioid/Substance Use Disorders
  • New York Attorney General Letitia James announced that Teva Pharmaceuticals will pay the state up to $523 million to settle claims related to its role in fueling the state’s opioid crisis. The funds are part of Teva’s $4 billion-plus global settlement, which also commits Teva to prohibit marketing opioids and funding third parties that promote them, in addition to banning high-dose opioids and prescription savings programs among other injunctive relief. (Articles here, here, and here)